What is RightBio Metrics?
RightBio Metrics specializes in innovative solutions for verifying NG/OG tube placement, primarily through their RightSpotpH® Indicator. This technology ensures accurate and safe tube placement without the need for radiation, catering to critical care environments such as NICU, ICU/PICU, and emergency departments. By providing immediate, evidence-based results, RightBio Metrics aims to eliminate the risks associated with misplaced tubes and enhance patient safety, thereby improving patient outcomes.
How much funding has RightBio Metrics raised?
RightBio Metrics has raised a total of $1.2M across 1 funding round:
Private Equity
$1.2M
Private Equity (2016): $1.2M, investors not publicly disclosed
What's next for RightBio Metrics?
The recent major strategic investment positions RightBio Metrics for accelerated growth and market penetration. This capital is expected to fuel further development of their tube placement verification technology and expand its adoption across a wider range of healthcare settings. The company's focus on radiation-free, accurate verification aligns with the growing demand for safer and more efficient medical procedures, suggesting a strong trajectory for future innovation and market leadership in patient safety solutions.
See full RightBio Metrics company page
